Sedana Medical Future Growth

Future criteria checks 2/6

Sedana Medical is forecast to grow earnings and revenue by 42.9% and 35.6% per annum respectively. EPS is expected to grow by 20.5% per annum. Return on equity is forecast to be -2.1% in 3 years.

Key information

42.9%

Earnings growth rate

20.5%

EPS growth rate

Medical Equipment earnings growth24.2%
Revenue growth rate35.6%
Future return on equity-2.1%
Analyst coverage

Low

Last updated29 Apr 2024

Recent future growth updates

Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Apr 28
Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Recent updates

Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Apr 28
Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Mar 16
Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking

Dec 21
Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking

We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Oct 29
We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans

Jul 12
Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans

Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts

May 01
Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts

We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Feb 17
We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Analysts Are More Bearish On Sedana Medical AB (publ) (STO:SEDANA) Than They Used To Be

Jan 20
Analysts Are More Bearish On Sedana Medical AB (publ) (STO:SEDANA) Than They Used To Be

Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Companies Like Sedana Medical (STO:SEDANA) Are In A Position To Invest In Growth

Jul 05
Companies Like Sedana Medical (STO:SEDANA) Are In A Position To Invest In Growth

Sedana Medical AB (publ) (STO:SEDANA) Analysts Just Slashed This Year's Estimates

May 03
Sedana Medical AB (publ) (STO:SEDANA) Analysts Just Slashed This Year's Estimates

Sedana Medical AB (publ) (STO:SEDANA) Just Reported And Analysts Have Been Cutting Their Estimates

Feb 20
Sedana Medical AB (publ) (STO:SEDANA) Just Reported And Analysts Have Been Cutting Their Estimates

We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Feb 16
We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Here's Why We're Not At All Concerned With Sedana Medical's (STO:SEDANA) Cash Burn Situation

Oct 26
Here's Why We're Not At All Concerned With Sedana Medical's (STO:SEDANA) Cash Burn Situation

Earnings and Revenue Growth Forecasts

OM:SEDANA - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026383134342
12/31/2025239-42-73362
12/31/2024188-54-221-432
3/31/2024165-23-204-23N/A
12/31/2023154-60-207-38N/A
9/30/2023145-57-224-69N/A
6/30/2023137-58-244-92N/A
3/31/2023127-71-240-95N/A
12/31/2022123-74-253-115N/A
9/30/2022133-54-238-94N/A
6/30/2022135-62-219-82N/A
3/31/2022148-68-177-55N/A
12/31/2021159-58-151-41N/A
9/30/2021159-53-144-37N/A
6/30/2021152-51-124-27N/A
3/31/2021153-38-105-13N/A
12/31/2020142-27-92-8N/A
9/30/2020116-22-85-14N/A
6/30/2020111-14-75-13N/A
3/31/202088-12-74-16N/A
12/31/201972-16-61-7N/A
9/30/201967-13-57-12N/A
6/30/201963-11-47-7N/A
3/31/201960-10-38-3N/A
12/31/201858-7-35-6N/A
9/30/201853-3-229N/A
6/30/201851-4-34-9N/A
3/31/201847-3-30-3N/A
12/31/201742-4N/A0N/A
9/30/201741-3N/A-7N/A
6/30/2017390N/A10N/A
3/31/2017360N/A0N/A
12/31/2016341N/A0N/A
12/31/201528-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SEDANA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SEDANA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SEDANA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SEDANA's revenue (35.6% per year) is forecast to grow faster than the Swedish market (1.7% per year).

High Growth Revenue: SEDANA's revenue (35.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SEDANA is forecast to be unprofitable in 3 years.


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.